Steven Stein
About Steven Stein
Steven H. Stein, M.D., serves as the Executive Vice President and Chief Medical Officer at Incyte, having joined the company in 2015 after holding significant roles in Novartis and GSK.
Steven H. Stein, M.D. - Executive Vice President and Chief Medical Officer
Steven H. Stein, M.D., serves as the Executive Vice President and Chief Medical Officer at Incyte. He joined the company in 2015, bringing with him vast experience in the pharmaceutical industry. In his role, Dr. Stein is responsible for overseeing clinical development and medical affairs, contributing to the strategic vision and operational excellence in developing innovative therapies.
Steven H. Stein, M.D. - Career at Novartis Pharmaceuticals
Before joining Incyte, Steven H. Stein, M.D., worked at Novartis Pharmaceuticals Corporation as the Senior Vice President of U.S. Clinical Development & Medical Affairs for Novartis Oncology. At Novartis, Dr. Stein played a crucial role in leading clinical development initiatives and shaping medical affairs strategies for oncology therapies.
Steven H. Stein, M.D. - Professional Experience at GSK
Prior to his tenure at Novartis, Steven H. Stein, M.D., served as Vice President, Global Oncology, Clinical Development at GSK (formerly GlaxoSmithKline). He was also the Head of Medicines Development for Hematology and Supportive Care. During his time at GSK, Dr. Stein led global clinical development programs and was instrumental in advancing hematology and supportive care medicines.
Steven H. Stein, M.D. - Academic Background and Fellowship
Steven H. Stein, M.D., completed a fellowship in Hematology and Oncology at the University of Pennsylvania. He also served as an Assistant Professor in the Department of Medicine at the same institution. Dr. Stein earned his medical degree from the University of Witwatersrand in Johannesburg, South Africa, providing a solid foundation for his career in clinical development and medical affairs.